Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
暂无分享,去创建一个
M. Gnant | G. Ricken | Z. Bago-Horvath | M. Preusser | P. Dubsky | F. Fitzal | G. Steger | R. Bartsch | B. Streubel | C. Zielinski | P. Birner | A. Berghoff | M. Rudas